1396.8000 -11.20 (-0.80%)
NSE Dec 18, 2025 15:31 PM
Volume: 474.7K
 

Geojit BNP Paribas
With persistent focus of service parameters and timely turnarounds, DLPL was able to achieve robust growth in volume during the pandemic. Leveraging its dedicated network driven infrastructure and techenabled processes, we expect the company to be able to perform well in the expected third wave situation. Hence, we upgrade our rating on the...
Dr. Lal Pathlabs Ltd. is trading below all available SMAs
More from Dr. Lal Pathlabs Ltd.
Recommended